Evidence map›Paper›PMID 28060727›Full record

ArticleOncotarget2017

Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.

Xibiao Ye, Kaiqiong Zhao, Cuie Wu, Pingzhao Hu, Hua Fu

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. The Influence ofIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xibiao YeDepartment of Community Health Sciences, College of Medicine, Faculty of Health Sciences, University of Manitoba, Canada.
Kaiqiong ZhaoCentre for Healthcare Innovation, University of Manitoba, Winnipeg, Manitoba, Canada.
Cuie WuSchool of Public Health, Fudan University, Shanghai, China.
Pingzhao HuCentre for Healthcare Innovation, University of Manitoba, Winnipeg, Manitoba, Canada.
Hua FuSchool of Public Health, Fudan University, Shanghai, China.
Fudan University · CNGeorge & Fay Yee Centre for Healthcare Innovation · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We undertook a hospital-based case-control study to examine the associations between single nucleotide polymorphisms (SNPs) in selected immunoregulatory genes and non-Hodgkin lymphoma (NHL) risk in a Chinese population. One hundred and sixty-nine NHL patients diagnosed according to the World Health Organization (WHO) 2001 standard and 421 controls were recruited. Nine SNPs in three genes (IL-10, IL-1RN, and TNF-α) were selected based on predicted functions and previous study findings. Genetic association analysis was performed using the Cochran-Armitage trend test and multiple logistic regression. Four SNPs were associated with an increased risk of overall NHL: odds ratio per minor allele [ORper-minor-allele] and 95% confidence interval [CI] were 2.64 (1.75-3.98) for IL-10 rs1800893, 2.67 (1.72-4.16) for IL-1RN rs4251961, 1.80 (1.24-2.63) for TNF- α rs1800630, and 1.55 (1.02-2.37) for TNF- α rs2229094. These SNPs were also associated with an increased risk of diffuse large B-cell lymphoma (DLBCL). In addition, another SNP (TNF- α rs1041981) was associated with an increased risk of DLBCL (ORper-minor-allele=1.73, 95% CI 1.14-2.61). The findings provide evidence on the role of these immunoregulatory gene variants in NHL etiology.

Indexed as

Polymorphism, Single NucleotideAgedAsian PeopleBiomarkers, TumorCase-Control StudiesChinaChi-Square DistributionFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansInterleukin-10Interleukin 1 Receptor Antagonist ProteinLogistic ModelsLymphoma, Large B-Cell, DiffuseLymphoma, Non-HodgkinBiomarkers, TumorIL10 protein, humanIL1RN protein, humanInterleukin-10Interleukin 1 Receptor Antagonist ProteinTumor Necrosis Factor-alphagenetic susceptibilitynon-Hodgkin lymphomasingle nucleotide polymorphism

Identifiers

PMID28060727
PMCPMC5354671
OpenAlexW2563678239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.